Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This clinical trial is designed as a single - arm, open - label, single - center, investigator - initiated early - phase clinical study. The primary objective is to evaluate the safety of UTAA91 injection in treating subjects with refractory moderate - to - severe active rheumatoid arthritis.
Epistemonikos ID: 3b92a3279bee8c743d616ea3912c45fd6c4dcc3d
First added on: May 22, 2025